Thursday, Dec 08th

Last update:10:30:34 AM GMT

Headlines:
Load a sample iFrame " href="/gujarati/others/vedio-gujarati">Video-Gujarati

Strides Arcolab gets US Nod for HIV Drugs

Strides Arcolab
Bangalore based drug maker Strides Arcolab has announced that the company has secured a tentative approval from the Food and Drug Administration in the US for a new drug application (NDA) with a combination drug containing Lamivudine and Stavudine.

The approval of the drug which is used for the treatment of AIDS, was expedited under the review provisions of the US President’s Emergency Plant for AIDS relief (PEPFAR).

According to the company, the approval has taken the company's total number of NDAs and abbreviated new drug application (ANDAs) approval under the PEPFAR programme to 11.

“This approval is yet another significant milestone in the front line of approvals for key HIV/AIDS medicines. This, combined with our pipeline of second line drugs will make us a significant player in the quality, affordable multisource anti–retroviral drugs (ARVs) business segment,” said VS Iyer, CEO, India Operations, Strides Arcolab.

The company supplies ARV products to global procurement agencies. The new approval adds to the overall basket of medicines available, said the company.

Disclaimer: The news story on this page is the copyright of the cited publication. This has been reproduced here for visitors to review, comment on and discuss. This is in keeping with the principle of ‘Fair dealing’ or ‘Fair use’. Visitors may click on the publication name, in the news story, to visit the original article as it appears on the publication’s website.

Source: Business Standard

સુચના

 
આ આપની સાઈટ છે, સુચના અથવા પ્રતિક્રીયા આવકાર્ય છે. જણાવશો, તો અમો તેના આધારે ઉત્તમ કરવાના પ્રયત્‍નો કરશું.

સુચના જણાવો

વાર્તાપત્ર

 
Newsletters

Link to Aarogya

 

પ્રકાશન

 
Know Your Rights!

અમારીસાથી આઓ